Clinical Trial: A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Thrombotic Thrombocytopenic Purpura (TTP)
Study Type: INTERVENTIONAL
Official Title: A Phase 2b, Multicenter, Randomized, Double-blind Study of Safety and Efficacy of TAK-755 (rADAMTS13) With Minimal to No Plasma Exchange (PEX) in the Treatment of Immune-mediated Thrombotic Thrombocyt
Brief Summary:
This is a study of TAK-755 in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP).The main aim of this study is to determine the percentage of participants with a clinical response without plasma exchange during the study.Participants who have an acute attack of iTTP will receive TAK-755 and immunosuppressive therapy during their stay at the hospital until they achieve a clinical response.Participants will also be treated with TAK-755 for an additional time of up to 6 weeks after the acute…
Read more